XETRA - Delayed Quote EUR

Novo Nordisk A/S (NOV.DE)

Compare
84.60
-0.26
(-0.31%)
At close: January 10 at 5:35:38 PM GMT+1
All numbers in thousands
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
314,486,000.00
241,257,000.00
194,508,000.00
144,922,000.00
Total Liabilities Net Minority Interest
207,925,000.00
157,771,000.00
123,762,000.00
81,597,000.00
Total Equity Gross Minority Interest
106,561,000.00
83,486,000.00
70,746,000.00
63,325,000.00
Total Capitalization
122,537,000.00
104,261,000.00
80,400,000.00
63,325,000.00
Common Stock Equity
106,561,000.00
83,486,000.00
70,746,000.00
63,325,000.00
Capital Lease Obligations
5,726,000.00
4,529,000.00
4,129,000.00
3,672,000.00
Net Tangible Assets
46,155,000.00
32,547,000.00
27,575,000.00
42,668,000.00
Working Capital
-30,009,000.00
-12,746,000.00
-13,921,000.00
-4,464,000.00
Invested Capital
127,841,000.00
104,741,000.00
93,262,000.00
70,009,000.00
Tangible Book Value
46,155,000.00
32,547,000.00
27,575,000.00
42,668,000.00
Total Debt
27,006,000.00
25,784,000.00
26,645,000.00
10,356,000.00
Net Debt
6,888,000.00
8,602,000.00
11,796,000.00
--
Share Issued
4,510,000.00
4,560,000.00
4,682,200.00
4,776,277.32
Ordinary Shares Number
4,458,287.95
4,499,800.00
4,620,000.00
4,700,000.00
Treasury Shares Number
51,712.05
60,200.00
62,200.00
76,277.32
12/31/2020 - 6/7/2001

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers